(Q40916988)

English

A multinational investigation of the impact of subcutaneous sumatriptan. IV: Patient satisfaction

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

A multinational investigation of the impact of subcutaneous sumatriptan. IV: Patient satisfaction (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

patient satisfaction

1 reference

based on heuristic

inferred from title

author name string

Bouchard J

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Cortelli P

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Dahlöf C

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Heywood J

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Jansen JP

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Price KL

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Pham S

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Joseph A

8

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Babiak L

9

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

1 January 1997

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

11 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

43-50

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of subcutaneous sumatriptan with usual acute treatments for migraine. French Sumatriptan Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational investigation of the impact of subcutaneous sumatriptan. III: Workplace productivity and non-workplace activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational investigation of the impact of subcutaneous sumatriptan. I: Design, methods and clinical findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Acute Migraine With Subcutaneous Sumatriptan

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral sumatriptan compared with placebo in the acute treatment of migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How does sumatriptan perform in clinical practice?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient attitudes about headache

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of subcutaneous sumatriptan in repeated episodes of migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199700111-00007

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40916988&oldid=2204088462"